Risk of cardiovascular events among celiac disease patients: A meta-analysis review
Saad Shams, Vanessa Vidaurre Corrales, Ibrahim Marouf Yasin Al Shyyab, Akshat Banga, Ameer Mustafa Farrukh, Moza Ali Alzaabi, Majd Atef Albeetar, Sem Josue Nsanh Yao, Kavya Remala, Mohamad Emad Aldeen Mahfouz, Navneeth Jayaprakash, Sawai Singh Rathore

TL;DR
This study reviews the link between celiac disease and cardiovascular events, finding no overall increased risk but higher chances of specific conditions like stroke and heart failure.
Contribution
The study provides a meta-analysis of cardiovascular risks in celiac disease patients, highlighting specific conditions of concern.
Findings
Celiac disease patients had a 9.3% prevalence of cardiovascular events.
No significant overall cardiovascular risk increase compared to the general population.
Higher risk of atrial fibrillation, stroke, heart failure, and cardiomyopathy was observed.
Abstract
A review on the association between celiac disease and cardiovascular events using multiple databases and random effects models is of interest. The overall prevalence of cardiovascular events in celiac patients was 9.3%. However, there was no significant increase in overall cardiovascular risk or myocardial infarction compared to the general population. Known data shows that celiac disease was linked to a higher risk of atrial fibrillation, stroke, congestive heart failure and cardiomyopathy. Thus, there is a need to monitor cardiovascular health in celiac patients to mitigate potential risks.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCeliac Disease Research and Management · Microbial Metabolites in Food Biotechnology
